The Clinicopathologic Significance of p53 and BAF250a (ARID1A) Expression in Clear Cell Carcinoma of the Endometrium

被引：0
作者：
Fadare, O.
Gwin, K.
Desouki, M. M.
Crispens, M. A.
Jones, H. W., III
Khabele, D.
Mohammed, K.
Liang, S. X.
Zheng, W.
Hecht, J. L.
Parkash, V.
机构：
[1] Vanderbilt Univ, Nashville, TN USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] UPMC, Pittsburgh, PA USA
[4] N Shore LIJ, Nhp, NY USA
[5] Univ Arizona, Tucson, AZ USA
[6] Harvard Univ, Boston, MA 02115 USA
[7] Yale Univ, New Haven, CT USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1138
引用
收藏
页码：273A / 273A
页数：1
相关论文
共 50 条
[11]   BAF250a (ARID1A) Combined with HNF-1b, ER and P53 Can Distinguish between Ovarian Clear Cell Carcinoma and Papillary Serous Carcinoma [J].
Xiao, W. ;
Awadallah, A. ;
Xin, W. .
MODERN PATHOLOGY, 2012, 25 :301A-301A
[12]   Loss of BAF250a (ARID1A) Expression Is Associated with Progression of Endometriosis-Related Stage I Ovarian Clear Cell Carcinoma [J].
Kawabata, Ayako ;
Kiyokawa, Takako ;
Yanaihara, Nozomu ;
Okamoto, Aikou .
LABORATORY INVESTIGATION, 2016, 96 :290A-290A
[13]   Loss of BAF250a (ARID1A) Expression Is Associated with Progression of Endometriosis-Related Stage I Ovarian Clear Cell Carcinoma [J].
Kawabata, Ayako ;
Kiyokawa, Takako ;
Yanaihara, Nozomu ;
Okamoto, Aikou .
MODERN PATHOLOGY, 2016, 29 :290A-290A
[14]   The ARID1A, p53 and β-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium [J].
Heckl, Marlene ;
Schmoeckel, Elisa ;
Hertlein, Linda ;
Rottmann, Miriam ;
Jeschke, Udo ;
Mayr, Doris .
PLOS ONE, 2018, 13 (02)
[15]   Effect of ARID1A/BAF250a expression on carcinogenesis and clinicopathological factors in pure-type clear cell adenocarcinoma of the ovary [J].
Kato, Masafumi ;
Takano, Masashi ;
Miyamoto, Morikazu ;
Sasaki, Naoki ;
Goto, Tomoko ;
Suzuki, Ayako ;
Hirata, Junko ;
Sasa, Hidenori ;
Tsuda, Hitoshi ;
Furuya, Kenichi .
MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (04) :395-401
[16]   ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts [J].
Wiegand, Kimberly C. ;
Sy, Keiyan ;
Kalloger, Steve E. ;
Li-Chang, Hector ;
Woods, Ryan ;
Kumar, Aalok ;
Streutker, Catherine J. ;
Hafezi-Bakhtiari, Sara ;
Zhou, Chen ;
Lim, Howard J. ;
Huntsman, David G. ;
Clarke, Blaise ;
Schaeffer, David F. .
HUMAN PATHOLOGY, 2014, 45 (06) :1258-1268
[17]   Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment [J].
Fadare, Oluwole ;
Renshaw, Idris L. ;
Liang, Sharon X. .
JOURNAL OF CANCER, 2012, 3 :129-136
[18]   ARID1A/BAF250a is significantly overexpressed in primary invasive breast cancer [J].
Szpon, Lukasz ;
Agrawal, Anil ;
Jelen, Michal ;
Lipinski, Artur ;
Rudnicki, Jerzy ;
Makuch, Sebastian ;
Wozniak, Marta ;
Szmit, Mateusz ;
Agrawal, Siddarth .
TRANSLATIONAL CANCER RESEARCH, 2020, 9 (06) :3937-3945
[19]   Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer [J].
Cho, Hanbyoul ;
Kim, Jane Seon-Young ;
Chung, Hyunsoo ;
Perry, Candice ;
Lee, Heejeong ;
Kim, Jae-Noon .
HUMAN PATHOLOGY, 2013, 44 (07) :1365-1374
[20]   BAF250a (ARIDIA) Combined with HNF-1b, ER and P53 Can Distinguish between Ovarian Clear Cell Carcinoma and Papillary Serous Carcinoma [J].
Xiao, W. ;
Awadallah, A. ;
Xin, W. .
LABORATORY INVESTIGATION, 2012, 92 :301A-301A
12345